
HALO
Healthcare · Biotechnology · $11.43B market cap
$100.27-0.40 (-0.4%)Nov 13, 4:02 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +1.3% over 90 days · 30-day revisions 2 up, 2 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | 2.17 | 2.27 | +4.6% |
| Aug 6, 2026 | After the close | 1.73 | 2.17 | +25.4% |
| May 11, 2026 | After the close | 1.76 | 1.22 | -30.6% |
| Feb 17, 2026 | After the close | 2.20 | -0.24 | -110.9% |
| Nov 3, 2025 | After the close | 1.63 | 1.72 | +5.5% |
| Aug 5, 2025 | After the close | 1.27 | 1.54 | +21.3% |
| May 6, 2025 | After the close | 0.95 | 1.11 | +16.8% |
| Feb 18, 2025 | Before the open | 1.16 | 1.26 | +8.7% |
| Oct 31, 2024 | After the close | 0.98 | 1.27 | +29.6% |
| Aug 6, 2024 | After the close | 0.76 | 0.91 | +19.7% |
| May 7, 2024 | After the close | 0.70 | 0.79 | +12.9% |
| Feb 20, 2024 | After the close | 0.83 | 0.82 | -1.2% |
| Nov 6, 2023 | After the close | 0.71 | 0.75 |
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as…
| +5.6% |
| Aug 8, 2023 | After the close | 0.64 | 0.74 | +15.6% |
| May 9, 2023 | After the close | 0.48 | 0.47 | -2.1% |
| Feb 21, 2023 | After the close | 0.47 | 0.48 | +2.1% |
| Nov 8, 2022 | After the close | 0.51 | 0.74 | +45.1% |
| Aug 9, 2022 | After the close | 0.50 | 0.53 | +6.0% |
| May 10, 2022 | After the close | 0.49 | 0.47 | -4.1% |
| Feb 22, 2022 | After the close | 0.41 | 0.42 | +2.4% |
| Nov 2, 2021 | After the close | 0.48 | 0.55 | +14.6% |
| Aug 9, 2021 | After the close | 0.44 | 0.66 | +50.0% |
| May 10, 2021 | After the close | 0.31 | 0.37 | +19.4% |
| Feb 23, 2021 | After the close | 0.53 | 0.50 | -5.7% |
| Nov 2, 2020 | After the close | 0.21 | 0.25 | +19.0% |
| Aug 10, 2020 | After the close | 0.25 | 0.19 | -24.0% |
| May 11, 2020 | After the close | -0.04 | -0.04 | 0.0% |
| Feb 24, 2020 | After the close | -0.14 | -0.24 | -71.4% |
| Nov 12, 2019 | After the close | -0.13 | -0.17 | -30.8% |
| Aug 6, 2019 | After the close | -0.15 | -0.10 | +33.3% |
| May 7, 2019 | After the close | 0.05 | 0.01 | -80.0% |
| Feb 21, 2019 | After the close | -0.03 | -0.01 | +66.7% |
| Nov 6, 2018 | After the close | -0.23 | -0.19 | +17.4% |
| Aug 7, 2018 | After the close | -0.22 | -0.16 | +27.3% |
| May 10, 2018 | After the close | -0.22 | -0.19 | +13.6% |
| Feb 20, 2018 | After the close | 0.77 | 0.85 | +10.4% |